140 related articles for article (PubMed ID: 18230771)
1. Strides made in red blood cell disorders, but substantial barriers to care remain.
Hampton T
JAMA; 2008 Jan; 299(4):395-6. PubMed ID: 18230771
[No Abstract] [Full Text] [Related]
2. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
Alvarez O; Yovetich NA; Scott JP; Owen W; Miller ST; Schultz W; Lockhart A; Aygun B; Flanagan J; Bonner M; Mueller BU; Ware RE;
Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242
[TBL] [Abstract][Full Text] [Related]
3. Investigational agents for sickle cell disease.
Okpala I
Expert Opin Investig Drugs; 2006 Aug; 15(8):833-42. PubMed ID: 16859388
[TBL] [Abstract][Full Text] [Related]
4. Iron chelation therapy for patients with sickle cell disease and iron overload.
Inati A; Khoriaty E; Musallam KM; Taher AT
Am J Hematol; 2010 Oct; 85(10):782-6. PubMed ID: 20721892
[No Abstract] [Full Text] [Related]
5. Sickle cell anaemia: current therapies.
Vermylen C
Transfus Apher Sci; 2013 Oct; 49(2):151-4. PubMed ID: 23954416
[TBL] [Abstract][Full Text] [Related]
6. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
[TBL] [Abstract][Full Text] [Related]
7. [Management of sickle cell disease].
de Montalembert M
Rev Prat; 2004 Sep; 54(14):1557-64. PubMed ID: 15558966
[TBL] [Abstract][Full Text] [Related]
8. Hematology clinic. Sickle cell disease.
Ngo D; Steinberg M
Hematology; 2014 Jun; 19(4):244-5. PubMed ID: 24666152
[No Abstract] [Full Text] [Related]
9. Sickle cell disease: new insights into pathophysiology and treatment.
Inati A; Koussa S; Taher A; Perrine S
Pediatr Ann; 2008 May; 37(5):311-21. PubMed ID: 18543542
[No Abstract] [Full Text] [Related]
10. Light and shadows in the iron chelation treatment of haematological diseases.
Maggio A
Br J Haematol; 2007 Aug; 138(4):407-21. PubMed ID: 17659052
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.
Vichinsky E; Pakbaz Z; Onyekwere O; Porter J; Swerdlow P; Coates T; Lane P; Files B; Mueller BU; Coïc L; Forni GL; Fischer R; Marks P; Rofail D; Abetz L; Baladi JF
Acta Haematol; 2008; 119(3):133-41. PubMed ID: 18408362
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease: What all PAs should know.
Kayinqo G
JAAPA; 2012 Sep; 25(9):19-20. PubMed ID: 22991882
[No Abstract] [Full Text] [Related]
13. Acute Liver Failure During Deferasirox Chelation: A Toxicity Worth Considering.
Menaker N; Halligan K; Shur N; Paige J; Hickling M; Nepo A; Weintraub L
J Pediatr Hematol Oncol; 2017 Apr; 39(3):217-222. PubMed ID: 28221265
[TBL] [Abstract][Full Text] [Related]
14. Iron chelation therapy in myelodysplastic syndrome - Cui bono?
Tefferi A; Stone RM
Leukemia; 2009 Aug; 23(8):1373. PubMed ID: 19672273
[No Abstract] [Full Text] [Related]
15. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
Tsouana E; Kaya B; Gadong N; Hemmaway C; Newell H; Simmons A; Whitmarsh S; Telfer P
Eur J Haematol; 2015 Apr; 94(4):336-42. PubMed ID: 25138173
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
Powars DR
J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
[No Abstract] [Full Text] [Related]
17. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.
Vichinsky E; Onyekwere O; Porter J; Swerdlow P; Eckman J; Lane P; Files B; Hassell K; Kelly P; Wilson F; Bernaudin F; Forni GL; Okpala I; Ressayre-Djaffer C; Alberti D; Holland J; Marks P; Fung E; Fischer R; Mueller BU; Coates T;
Br J Haematol; 2007 Feb; 136(3):501-8. PubMed ID: 17233848
[TBL] [Abstract][Full Text] [Related]
18. Hypocalcemia in a dialysis patient treated with deferasirox for iron overload.
Yusuf B; McPhedran P; Brewster UC
Am J Kidney Dis; 2008 Sep; 52(3):587-90. PubMed ID: 18534729
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of hydroxyurea for sickle cell anemia.
Hagar W
JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
[No Abstract] [Full Text] [Related]
20. The clinical care of adult patients with sickle cell disease.
Olujohungbe A; Howard J
Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
